UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cell-free DNA screening and sex chromosome aneuploidies

Prenatal diagnosis, 2015-10, Vol.35 (10), p.980-985

2015

Volltextzugriff (PDF)

Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?

American journal of obstetrics and gynecology, 2013-11, Vol.209 (5), p.415-419

2013

Volltextzugriff (PDF)

The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction

Prenatal diagnosis, 2017-11, Vol.37 (11), p.1125-1129

2017

Volltextzugriff (PDF)

The benefits and limitations of cell‐free DNA screening for 22q11.2 deletion syndrome

Prenatal diagnosis, 2017-01, Vol.37 (1), p.53-60

2017

Volltextzugriff (PDF)

CCBE1 mutation in two siblings, one manifesting lymphedema-cholestasis syndrome, and the other, fetal hydrops

PloS one, 2013-09, Vol.8 (9), p.e75770-e75770

2013

Volltextzugriff (PDF)

Cell-free fetal DNA testing: who is driving implementation?

Genetics in medicine, 2013-06, Vol.15 (6), p.433-434

2013

Volltextzugriff (PDF)

The Recurrent t(11;22)(q23;q11.2) Can Occur as a Post-Zygotic Event

Cytogenetic and genome research, 2018-01, Vol.156 (4), p.185-190

2018

Volltextzugriff (PDF)

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel

Genetics in medicine, 2004-09, Vol.6 (5), p.387-391

2004

Volltextzugriff (PDF)

Beare-Stevenson syndrome: Two new patients, including a novel finding of tracheal cartilaginous sleeve

American journal of medical genetics. Part A, 2015-04, Vol.167A (4), p.852-857

2015

Volltextzugriff (PDF)

Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop

Obstetrics and gynecology (New York. 1953), 2006-01, Vol.107 (1), p.167-173

2006

Volltextzugriff (PDF)

Risks of second-trimester amniocentesis: why all the fuss 30 years later?

Obstetrics and gynecology (New York. 1953), 2008-03, Vol.111 (3), p.586-588

Mennuti, Michael T

2008

Volltextzugriff (PDF)

Genetic Screening in Reproductive Health Care

Clinical obstetrics and gynecology, 2008-03, Vol.51 (1), p.3-23

MENNUTI, MICHAEL T

2008

Volltextzugriff (PDF)

Is It Time to Sound an Alarm About False-Positive Cell-Free DNA Testing for Fetal Aneuploidy?

Obstetrical & gynecological survey, 2014-03, Vol.69 (3), p.135-136

2014

Volltextzugriff (PDF)

Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis

Genetics in medicine, 2004-09, Vol.6 (5), p.450-455

2004

Volltextzugriff (PDF)

Embracing change in obstetrics and gynecology

Obstetrics and gynecology (New York. 1953), 2005-11, Vol.106 (5 Pt 1), p.904-907

Mennuti, Michael T

2005

Volltextzugriff (PDF)

Screening for Down's Syndrome — Too Many Choices?

The New England journal of medicine, 2003-10, Vol.349 (15), p.1471-1473

2003

Volltextzugriff (PDF)

Prompt diagnosis of ectopic pregnancy in an emergency department setting

Obstetrics and gynecology (New York. 1953), 1994-12, Vol.84 (6), p.1010

1994

Volltextzugriff (PDF)

Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening

Obstetrics and gynecology (New York. 1953), 2005-06, Vol.105 (6), p.1355-1361

2005

Volltextzugriff (PDF)

Are doctors prepared for direct-to-consumer advertising of genetic tests?

Obstetrics and gynecology (New York. 1953), 2008-04, Vol.111 (4), p.991, author reply 991

Mennuti, Michael

2008

Volltextzugriff (PDF)

Screening for cystic fibrosis carrier state

Obstetrics and gynecology (New York. 1953), 1999-03, Vol.93 (3), p.456-461

1999

Volltextzugriff (PDF)

The Association Between Anticoagulation Therapy, Maternal Characteristics, and a Failed cfDNA Test Due to a Low Fetal Fraction

Obstetrical & gynecological survey, 2018-03, Vol.73 (3), p.137-138

2018

Volltextzugriff (PDF)

17: Are elevated cell-free DNA levels observed with NIPT associated with preterm birth?

American journal of obstetrics and gynecology, 2015, Vol.212 (1), p.S12-S12

2015

Volltextzugriff (PDF)

Cystic fibrosis carrier screening: Issues in implementation

Genetics in medicine, 2002-11, Vol.4 (6), p.407-409

2002

Volltextzugriff (PDF)

Reply

American journal of obstetrics and gynecology, 2014-07, Vol.211 (1), p.81

2014

Volltextzugriff (PDF)

Estimation of the Risk of Thrombocytopenia in the Offspring of Pregnant Women with Presumed Immune Thrombocytopenic Purpura

The New England journal of medicine, 1990-07, Vol.323 (4), p.229-235

1990

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(130)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cell-free DNA screening and sex chromosome aneuploidies

Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?

The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction

The benefits and limitations of cell‐free DNA screening for 22q11.2 deletion syndrome

CCBE1 mutation in two siblings, one manifesting lymphedema-cholestasis syndrome, and the other, fetal hydrops

Cell-free fetal DNA testing: who is driving implementation?

The Recurrent t(11;22)(q23;q11.2) Can Occur as a Post-Zygotic Event

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel

Beare-Stevenson syndrome: Two new patients, including a novel finding of tracheal cartilaginous sleeve

Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop

Risks of second-trimester amniocentesis: why all the fuss 30 years later?

Genetic Screening in Reproductive Health Care

Is It Time to Sound an Alarm About False-Positive Cell-Free DNA Testing for Fetal Aneuploidy?

Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis

Embracing change in obstetrics and gynecology

Screening for Down's Syndrome — Too Many Choices?

Prompt diagnosis of ectopic pregnancy in an emergency department setting

Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening

Are doctors prepared for direct-to-consumer advertising of genetic tests?

Screening for cystic fibrosis carrier state

The Association Between Anticoagulation Therapy, Maternal Characteristics, and a Failed cfDNA Test Due to a Low Fetal Fraction

17: Are elevated cell-free DNA levels observed with NIPT associated with preterm birth?

Cystic fibrosis carrier screening: Issues in implementation

Reply

Estimation of the Risk of Thrombocytopenia in the Offspring of Pregnant Women with Presumed Immune Thrombocytopenic Purpura

Suchergebnisse filtern